The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

BACKGROUND: Metabolomic processes have been identified as being strongly linked to the development of Alzheimer's disease (AD). Thus, lipid metabolites appear to be highly useful as diagnostic substrates for the diagnosis of AD and mild cognitive impairment (MCI) in plasma. METHODS: We analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Klavins, Kristaps, Koal, Therese, Dallmann, Guido, Marksteiner, Josef, Kemmler, Georg, Humpel, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Blood-Based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700585/
https://www.ncbi.nlm.nih.gov/pubmed/26744734
http://dx.doi.org/10.1016/j.dadm.2015.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700585/
https://www.ncbi.nlm.nih.gov/pubmed/26744734
http://dx.doi.org/10.1016/j.dadm.2015.05.003

Ejemplares similares